
Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes
Keywords: Myelodysplastic syndromes; DNA damage response; pNBS1; pATM; γH2AX;